Liang's AIxBIO foundry
Liang ChangI'm a Biotech VC, PhD Cancer Biologist, AI enthusiastic and practitioner. I write about AI, biotech, books, podcasts, and everything I learned at the intersection
| Platform |  | Pricing | Only free issues | Publishes | Weekly |
|---|---|---|---|---|---|
| Issues | 15 | Founded | 9 months ago | Last Issue | 16 days ago |
| Active | |||||
Read this Newsletter
liangchang.substack.comLatest Issues
Human Genetics Doubled Drug Development Success. Two Failures This Summer Showed Why It’s a Powerful Foundation, Not The Finish Line.
Liang Chang and Mary Helen Black
Over the past decade, human genetics quietly became the most reliable de-risking tool in drug development. Drug mechanisms with human genetic support have roughly 2 times to 2.6 times the probability of rea...
Towards Biomedical Superintelligence: from AI agents to AI innovators
Jorge S. Reis-Filho & Liang Chang
Artificial intelligence is approaching its most important transition: from systems that retrieve, reason and execute within an existing evidence base to systems capable of expanding that evidence base thro...
The Anti-Scaling Law in Biology, and Why AI Could Make Crowding Worse Before Making Drug Development Better
In the last two weeks, two clinical trial readouts drew tremendous excitement well beyond the biopharma community.
At the plenary of the world’s largest cancer meeting, a room of oncologists stood and applauded the biggest win in pancreati...
I Asked 2 AI Agent Teams to Run 20 Biopharma Decisions. They Agreed With Each Other More Than With Reality but Could Save History in Some Cases...
I built an AI agent team as biopharma executives, and sent them to the boardrooms where historical high-stakes strategic decisions took place, on a time machine.
In June 2012, both Claude Opus 4.6 and ChatGPT-5.3 AI agent teams, acting as...
The Quest to Drug KRAS: 40 Years, 8,491 Abstracts, 6 Eras, 4 Drugs, 2 Pockets, 1 Pivotal Moment
On April 13, Revolution Medicines reported topline data from RASolute 302, the Phase 3 trial of pan-RAS inhibitor daraxonrasib monotherapy against chemotherapy in 2L metastatic pancreatic cancer patients with KRAS G12X mutations. Median OS...
Key Facts
Audience Metrics
Subscribers, engagement, traffic and sponsorship for Liang's AIxBIO foundry.
| Subscribers | Engagement | 73 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
Biotech x AI Builder and VC, Harvard PhD in Cancer Biology, AI enthusiast and practitioner
Frequently Asked Questions
How can I access the email archive for Liang's AIxBIO foundry?
You can find recent issues that have been published by Liang's AIxBIO foundry on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Liang's AIxBIO foundry have?
To see how many people subscribe to Liang's AIxBIO foundry, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Liang's AIxBIO foundry?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Liang's AIxBIO foundry as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Liang's AIxBIO foundry?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Liang's AIxBIO foundry using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to Liang's AIxBIO foundry?
Scroll up to where it says Related Newsletters to see other publications like Liang's AIxBIO foundry. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Liang's AIxBIO foundry?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.